# Annovis Bio, Inc.: Form 8-K, filed Jul 10, 2024

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: 8-K
- Filed: 2024-07-10
- Accepted by EDGAR: Jul 10, 2024, 16:05 ET
- Period: 2024-07-10
- Accession: 0001104659-24-078937
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465924078937/tm2419203d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465924078937/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465924078937/tm2419203d1_8k.htm

Filed Jul 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-078937. Last ingested by Listed: Nov 4, 2026, 18:44 ET. No prices; not investment advice.